Nasdaq 100 Stocks SEC Filings — July 24, 2026

Revenue grew 22.8% YoY to $5.463B, net income surged 52.9% YoY to $1.980B, and H1 operating cash flow jumped 55.9% to $4.223B—all while inventories declined 4.1% H1. This signals strong pricing power and operational efficiency.

Gross margin improved 1,290 bps YoY to 40.4% (from 27.5%), and operating income swung to +$1.8B from -$3.2B. The core Products segment (CCG + DCAI) generated $4.8B operating income, proving the turnaround is gaining traction.

Analog segment revenue grew 26.4% YoY to $4.365B, outperforming Embedded Processing (+16.1% YoY). Analog is TI's highest-margin segment, driving the 52.9% net income growth.

Net loss widened to $11.0B in Q2 2026 from $2.9B loss in Q2 2025, driven by a $13.6B mark-to-market loss on Escrowed Shares. This non-operating charge is a one-time event but signals high financial risk from the Altera-related structure.

H1 2026 revenue from China grew 24.1% YoY to $2.247B (22% of total), while US revenue grew 21.8% to $3.927B. China exposure is rising, creating geopolitical risk but also capturing demand. [BULLISH/BEARISH]

Insider Buckley Jeffrey was awarded 17,124 Stock Appreciation Rights (SARs). This is a retention tool, not a market purchase, but it aligns management with long-term shareholder value. [NEUTRAL/BULLISH]

Total equity fell from $126.4B to $103.1B (a decline of $23.3B), primarily due to the net loss and the Escrowed Shares charge. This weakens the balance sheet and may limit future capital allocation flexibility.

H1 2026 total CHIPS Act benefits of $1.405B are a significant cash flow tailwind, supporting the company's aggressive capital expenditure plans for 300mm wafer fabs.

Intel Foundry posted a $2.1B operating loss in Q2 2026, continuing to drag on overall profitability. The foundry strategy is still in investment phase with no near-term profitability in sight.

'Other' segment revenue declined 2.2% YoY to $310M, and operating profit slipped 2.0% YoY. This is a small segment but shows not all TI businesses are recovering equally. [NEUTRAL/BEARISH]

The $13.6B mark-to-market loss on Escrowed Shares (related to Altera) is a non-operating charge that wiped out operating profits. This structure creates ongoing volatility in net income and equity.

Total equity declined 18.4% from $126.4B to $103.1B in just one quarter. If this trend continues, debt covenants or credit ratings could be at risk.

Intel Foundry operating loss of $2.1B in Q2 2026 is a significant drag on the core business. The foundry segment is capital-intensive and may require years of investment before profitability.

H1 2026 China revenue grew to $2.247B (22% of total), up from 21% in H1 2025. Any escalation in US-China trade tensions or semiconductor export controls could materially impact revenue.

$170M in restructuring charges in Q2 2026, with more expected as the company continues its turnaround. Restructuring can disrupt operations and delay product roadmaps.

The 8-K filing contains no financial results, operational updates, or material events—only a routine investor presentation. This is a non-event that could distract investors from real catalysts.

Interest and other, net swung to a $12.6B expense in Q2 2026 from $95M in Q2 2025. While the Escrowed Shares charge is the main driver, the company's debt load is increasing.

Inventories decreased 4.1% H1 to $4.605B. While this signals demand outstripping supply, it also raises the risk of stock-outs if demand accelerates further.

Gross margin improved 1,290 bps YoY to 40.4%, and operating income turned positive. If the company can manage non-operating charges, the core business is recovering. Trading at a discount to peers due to the net loss.

Analog revenue grew 26.4% YoY, and the segment is TI's highest-margin. With $1.405B in CHIPS Act benefits and a 55.9% surge in operating cash flow, TI has ample capital to invest in capacity and return to shareholders.

Intel Products (CCG + DCAI) generated $4.8B operating income in Q2 2026. This segment is the core of Intel's value and is performing well despite the Foundry drag.

H1 2026 operating cash flow of $4.223B (up 55.9% YoY) provides a strong foundation for dividend growth, buybacks, and capex. The company is a cash flow compounder.

The award of 17,124 SARs to a key executive aligns management with stock price appreciation. Palantir's government and AI contracts are growing, and insider retention is a positive signal.

If Intel Foundry can achieve profitability (currently at -$2.1B operating loss), the upside is significant given the global demand for advanced chip manufacturing. The CHIPS Act provides a tailwind.

Embedded Processing revenue grew 16.1% YoY to $788M. This segment is benefiting from industrial and automotive demand recovery.

Revenue grew 25% YoY to $16.1B in Q2 2026, driven by CCG and DCAI. If this growth continues, the operating leverage from the improved gross margin will drive significant earnings power.

Both Intel and Texas Instruments reported strong revenue growth (25% and 22.8% YoY, respectively), but the bottom-line outcomes are polar opposites. TI's net income surged 52.9% YoY, while Intel's net loss widened to $11.0B. The key differentiator is balance sheet management and non-operating charges. Investors should favor companies with clean financial structures. [IMPLICATION: Favor TI over INTC]

TI's Analog segment grew 26.4% YoY, outperforming its Embedded Processing (+16.1% YoY). Intel's CCG (client computing) and DCAI (data center/AI) are also strong. The pattern suggests broad-based semiconductor demand recovery, with analog and AI-related segments leading. [IMPLICATION: Overweight analog and AI-exposed names]

Both TI and Intel have significant China revenue. TI's China revenue grew 24.1% YoY to $2.247B (22% of total). This creates a double-edged sword: strong demand but geopolitical risk. [IMPLICATION: Monitor US-China trade policy]

TI is generating strong cash flow ($4.223B H1) and investing in capacity with CHIPS Act support. Intel's equity base is shrinking ($23.3B decline) due to non-operating charges, limiting its ability to invest or return capital. [IMPLICATION: TI is a capital allocation winner; Intel is a work in progress]

Palantir's insider equity award (17,124 SARs) is a retention tool, not a market purchase. In the absence of insider selling across the four filings, management appears aligned with long-term value creation. [IMPLICATION: No red flags from insider activity]

Q2 2026 results show a mixed picture. Watch for management's commentary on the Escrowed Shares charge, Foundry roadmap, and any guidance on non-operating expenses. Next earnings call expected in late October 2026.

With China revenue growing to 22% of total, any escalation in US-China trade tensions or semiconductor export controls could materially impact TI's revenue. Monitor trade policy announcements.

The $2.1B operating loss in Foundry is a key metric to track. Watch for any announcements of major foundry customers or milestones that could accelerate the path to profitability.

With $1.405B in CHIPS Act benefits, TI is investing heavily in 300mm wafer fabs. Watch for updates on capacity expansion timelines and any impact on margins.

The 17,124 SARs award to Buckley Jeffrey is a retention signal. Watch for any insider selling in subsequent filings, which could indicate a change in sentiment.

The 8-K filing is routine, but the investor presentation (Exhibit 99.1) may contain forward-looking statements or strategic updates. Review the presentation for any material information.

Total equity declined 18.4% in one quarter. Watch for any further deterioration or steps to stabilize the balance sheet (e.g., asset sales, debt restructuring).

Both Intel and TI are beneficiaries of the CHIPS Act. Watch for further disbursement announcements that could provide cash flow tailwinds.